title: Chemokines and BPH/LUTS.
abstract: A wealth of published studies indicate that a variety of chemokines are actively secreted by the prostatic microenvironment consequent to disruptions in normal tissue homeostasis due to the aging process or inflammatory responses. The accumulation of senescent stromal fibroblasts, and, possibly, epithelial cells, may serve as potential driving forces behind chemokine secretion in the aging and enlarged human prostate. Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) and histological inflammation may also potentially serve as rich sources of chemokine secretion in the prostate. Once bound to their cognate receptors, chemokines can stimulate powerful pro-proliferation signal transduction pathways and thus function as potent growth factors in the development and progression of Benign Prostatic Hyperplasia (BPH) and lower urinary tract symptoms (LUTS). These functions have been amply demonstrated experimentally and particularly point to robust Mitogen Activated Protein Kinase (MAPK) and phosphoinositide 3-kinase (PI3K) signaling, as well as global transcriptional responses, which mediate chemokine-stimulated cellular proliferative responses. A small body of literature also suggests that chemokine-mediated angiogenesis may comprise a contributing factor to BPH/LUTS development and progression. Thus, the observed low-level secretion of multiple chemokines within the aging prostatic microenvironment may promote a concomitant low-level, but cumulative, over-proliferation of both stromal fibroblastic and epithelial cell types associated with increased prostatic volume. Though the accumulated evidence is far from complete and suffers from some rather extensive gaps in knowledge, it argues favorably for the conclusion that chemokines can, and likely do, promote prostatic enlargement and the associated lower urinary tract symptoms, and justifies further investigations examining chemokines as potential therapeutic targets to delay or ablate BPH/LUTS initiation and progression.
authors: Department of Urology, The University of Michigan School of Medicine, 6217 Comprehensive Cancer Center, 1500 East Medical Center Drive, Ann Arbor, MI 48109-0944, USA. jcoska@umich.edu
authors: Jill A
authors: JA
authors: Macoska
references: Mol Pharmacol. 2007 Aug;72(2):219-30
references: 17430994
references: Am J Pathol. 2000 Mar;156(3):813-9
references: 10702397
references: J Cell Physiol. 2007 Dec;213(3):589-602
references: 17786953
references: Front Biosci. 1997 Jan 01;2:d12-26
references: 9159205
references: Int J Antimicrob Agents. 2008 Feb;31 Suppl 1:S85-90
references: 18164907
references: J Urol. 2004 Dec;172(6 Pt 1):2421-5
references: 15538284
references: Cytokine. 2008 Aug;43(2):194-9
references: 18572414
references: J Biol Chem. 1998 Jan 23;273(4):1839-42
references: 9442012
references: Eur Urol. 2002 Oct;42(4):323-8
references: 12361895
references: Urology. 2008 Mar;71(3):475-9; discussion 479
references: 18342190
references: Aging Cell. 2005 Dec;4(6):291-8
references: 16300481
references: J Clin Epidemiol. 2001 Sep;54(9):935-44
references: 11520654
references: Science. 2002 May 31;296(5573):1636-9
references: 12040175
references: J Urol. 1998 Apr;159(4):1224-8
references: 9507840
references: J Leukoc Biol. 2001 Dec;70(6):839-48
references: 11739545
references: Cancer Res. 2006 Jan 15;66(2):794-802
references: 16424011
references: Urology. 2000 Dec 20;56(6):1025-9
references: 11113752
references: Urology. 2001 Dec;58(6 Suppl 1):5-16; discussion 16
references: 11750242
references: Urology. 1998 Nov;52(5):744-9
references: 9801092
references: J Leukoc Biol. 2001 Apr;69(4):513-21
references: 11310836
references: J Urol. 2008 May;179(5):1736-40
references: 18343414
references: J Biol Chem. 1995 Nov 10;270(45):27348-57
references: 7592998
references: Prostate. 2003 Apr 1;55(1):30-8
references: 12640658
references: Prostate Cancer Prostatic Dis. 2003;6(2):131-7
references: 12806371
references: Prostate. 2009 Mar 1;69(4):373-84
references: 19021203
references: Prostate. 2010 Mar 1;70(4):377-89
references: 19866464
references: Urology. 2008 Jul;72(1):205-13
references: 18314176
references: Exp Cell Res. 2011 Mar 10;317(5):655-63
references: 21146524
references: Lab Invest. 1992 Jan;66(1):96-107
references: 1370561
references: Annu Rev Immunol. 2004;22:891-928
references: 15032599
references: Prostate. 2010 Apr 1;70(5):473-81
references: 19902472
references: Nature. 1998 Apr 9;392(6676):565-8
references: 9560152
references: Mol Vis. 1999 Nov 03;5:33
references: 10562657
references: Front Biosci (Landmark Ed). 2009 Jan 01;14:2386-99
references: 19273207
references: Clin Cancer Res. 1995 May;1(5):473-80
references: 9816006
references: J Biol Chem. 2007 Sep 14;282(37):26767-26774
references: 17631494
references: PLoS Biol. 2008 Dec 2;6(12):2853-68
references: 19053174
references: Int J Androl. 2001 Feb;24(1):37-47
references: 11168649
references: Am J Pathol. 1999 Apr;154(4):1125-35
references: 10233851
references: Am J Epidemiol. 2005 Nov 1;162(9):898-906
references: 16177142
references: Prostate. 2009 Dec 1;69(16):1774-80
references: 19670242
references: Adv Protein Chem. 2007;74:67-93
references: 17854655
references: J Biol Chem. 1994 Aug 19;269(33):21103-9
references: 8063729
references: Urology. 2009 Aug;74(2):340-4
references: 19464042
references: Oral Dis. 1997 Sep;3(3):162-6
references: 9467359
references: Cell Prolif. 2009 Dec;42(6):799-812
references: 19735466
references: Arterioscler Thromb Vasc Biol. 2008 Nov;28(11):1928-36
references: 18757292
references: Br J Pharmacol. 2006 Jan;147 Suppl 1:S46-55
references: 16402120
references: Prostate. 1995 Mar;26(3):111-5
references: 7534916
references: Proc Natl Acad Sci U S A. 1995 Sep 26;92(20):9363-7
references: 7568133
references: Lab Invest. 2003 Aug;83(8):1131-46
references: 12920242
references: Science. 2005 Aug 5;309(5736):886-7
references: 16081723
references: J Immunol. 2009 Apr 1;182(7):4056-64
references: 19299703
references: Eur Urol. 1996;29(3):345-54
references: 8740022
references: Acta Anat (Basel). 1996;155(1):63-72
references: 8811117
references: Nature. 1994 Jun 2;369(6479):418-20
references: 8196770
references: Differentiation. 1998 Jul;63(3):131-40
references: 9697307
references: Scand J Urol Nephrol Suppl. 1988;107:26-31
references: 2453919
references: J Clin Invest. 2004 Nov;114(9):1299-307
references: 15520862
references: Science. 1991 May 10;252(5007):802-8
references: 1902986
references: N Engl J Med. 2006 Feb 9;354(6):610-21
references: 16467548
references: Biochim Biophys Acta. 2007 Apr;1768(4):794-807
references: 17188232
references: Arthritis Rheum. 2005 Mar;52(3):710-21
references: 15751074
references: Cell Mol Life Sci. 2008 Jul;65(14):2191-214
references: 18488142
references: J Immunol. 2004 Aug 15;173(4):2231-5
references: 15294933
references: Annu Rev Med. 2006;57:195-206
references: 16409145
references: Trends Immunol. 2005 Mar;26(3):150-6
references: 15745857
references: Eur Urol. 2007 May;51(5):1202-16
references: 17182170
references: Urology. 1994 Jul;44(1):64-70
references: 7518983
references: Br J Urol. 1998 Sep;82(3):380-5
references: 9772874
references: BJU Int. 1999 Dec;84(9):976-81
references: 10571623
references: J Urol. 2000 Jul;164(1):214-8
references: 10840462
references: Transpl Immunol. 2002 May;9(2-4):165-71
references: 12180826
references: Proc Natl Acad Sci U S A. 1994 Dec 20;91(26):12706-10
references: 7809106
references: Prostate. 2000 Sep 15;45(1):1-7
references: 10960837
references: Prostate. 2002 Jun 1;52(1):43-58
references: 11992619